ERIN JABLONSKI: Open Payments
NPI 1902326689 · KEENE, NH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$138 in 5 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $138
Food & beverage: $138
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 1 | $40 |
| Ethicon US, LLC | 1 | $31 |
| Gilead Sciences, Inc. | 1 | $26 |
| Galderma Laboratories, L.P. | 1 | $22 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
Products named: DUPIXENT, STRATAFIX, ENTYVIO.
Industry payments across NH — which companies pay providers there.
